packageAtezolizumab

atezolizumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Atezolizumab is a monoclonal antibody that blocks PD-L1 and is used to treat several cancers, including bladder, lung, breast, and colorectal cancers. It is approved and authorised in the European Union, where it is used in cancer care.

Summary written by glm-5.3-flash from Wikidata Q20707748 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:atezolizumab
ATC codes:L01FF05, L01XC32
DrugBank:DB11595
Wikidata:Q20707748
molar mass:145000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown